関連する実験動画
Updated: Jul 13, 2026
10:43
Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice
Published on: October 31, 2007
糖尿病とトランスジェニックマウスにおける耐性 臓β細胞におけるII級MHC分子を発現するトランスジェニックマウスにおける糖尿病と耐性
1Laboratory of Reproductive Physiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia 19104.
Cell
|April 8, 1988
まとめ
ベータ細胞のクラスIIメジャー・ヒストコンパティビリティ・コンプレックス (MHC) 分子の異常発現は,トランスジェニックマウスでは自己免疫糖尿病を誘発しなかった. これらの発見は,MHC発現だけでは,組織特異抗原に対する自己免疫反応を開始するのに不十分であることを示唆しています.
科学分野:
- 免疫学 免疫学とは
- エンドクリノロジー エンドクリノロジー
- 遺伝学 遺伝学とは
背景:
- インスリン依存型糖尿病は,インスリンを産生するベータ細胞の喪失によるものです.
- ベータ細胞のクラスIIメジャー・ヒストコンパティビリティ・コンプレックス (MHC) 分子の異常発現は,自己免疫攻撃を誘発すると仮定されている.
- ベータ細胞自己免疫のメカニズムを理解することは,糖尿病治療の開発に不可欠です.
研究 の 目的:
- ベータ細胞のクラスIIのMHC分子の発現が自己免疫反応を誘発するかどうかを調査する.
- 非リンパ性細胞の異常MHC発現が,自己免疫糖尿病を引き起こすのに十分であるかどうかを判断する.
主な方法:
- クラスIIのMHC分子 (I-Eb) を特異的にベータ細胞に発現するトランスジェニックマウスの生成.
- 糖尿病の発症に対するトランスジェニックの子孫のモニタリング.
- 感染したマウスのTリンパ球反応と組織浸透の分析.
主要な成果:
- トランスジェニックマウスの100%がリンパ球の浸透に関係なく糖尿病を発症した.
- Tリンパ球は,トランスゲンI-Eb分子に対して耐性を示した.
- 胸腺またはリンパ球組織におけるI-Eb発現の欠如は,糖尿病の発症を予防しませんでした.
結論:
- 非リンパ球細胞のクラスIIのMHC分子の新しい発現は,自己免疫反応を開始するのに不十分です.
- MHC分子のみのベータ細胞発現は,糖尿病につながる自己免疫攻撃を誘発しません.
- ベータ細胞自身免疫の基礎となる完全なメカニズムを解明するために,さらなる研究が必要である.
関連する概念動画
01:36Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.